Int J Stomatol

Int J Stomatol ›› 2023, Vol. 50 ›› Issue (1): 43-51.doi: 10.7518/gjkq.2023012

• Oral Microbiology • Previous Articles     Next Articles

Research progress on oral flora changes affecting the course of radiotherapy and chemotherapy-related oral mucositis

Yang Mingyan1(),Zhang Fan2,Zhao Lei1()   

  1. 1.State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Periodontology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
    2.Health Management Center of West China Hospital, Sichuan University, Chengdu 610041, China
  • Received:2022-06-30 Revised:2022-09-12 Online:2023-01-01 Published:2023-01-09
  • Contact: Lei Zhao E-mail:1469691138@qq.com;jollyzldoc@163.com
  • Supported by:
    Sichuan Province Cadre Health Care Scientific Research Project-Popularization and Application Project(2022-109)

RichHTML

21

PDF (PC)

444

Abstract:

Head and neck radiotherapy and chemotherapy (referred to as chemoradiotherapy) can cause changes in oral microbiota diversity and community structure, including decreased abundance of health-related commensal bacteria, increased abundance of some Gram-negative bacteria, and changes in the fungal community dominated by increase in Candida albicans. These changes can lead to an increase in the risk and severity of oral mucositis (OM). Chemoradiotherapy causes direct or indirect DNA damage through reactive oxygen species, promotes the dysbacteriosis of microbial flora, destroys the immune system, and enhances inflammation. Cell damage forms ulcers, leading to bacterial translocation and colonization. In addition, nuclear factor-κB, Toll-like receptor, and other signaling pathways are activated, thus inducing the expression of pro-inflammatory cytokines and promoting the development of OM. The treatment of OM is currently a research hotspot for oral flora regulation. Probiotics or probiotic mixtures can be used to prevent and treat OM, and the prophylactic use of antifungal agents can reduce the number of oral Candida infections. This paper reviews the effects of head and neck chemoradiotherapy on oral microflora changes and their correlation with OM to provide new ideas for the prevention and treatment of chemotherapy-related OM.

Key words: radiotherapy, chemotherapy, head and neck cancer, changes in oral flora, oral mucositis

CLC Number: 

  • R 780.2

TrendMD: 

Tab 1

Grading of OM related to radiotherapy and chemotherapy"

分级标准分级临床表现
RTOG[21]急性放射性黏膜炎分级标准1红斑
2斑点反应（<1.5 cm，不连续）
3融合性黏膜炎（>1.5 cm，连续）
4溃疡、坏死、出血
WHO[22]口腔毒性量表0无明显症状
1口腔酸痛，红斑
2口腔红斑、溃疡，可以吃固体
3口腔溃疡，只能进食流质饮食
4不能从口腔摄入营养
NCI—不良事件通用术语标准（5.0版[23]和4.0版[21]）1无症状或轻微症状；无需治疗
2不影响经口摄入的中度疼痛或溃疡；需改变饮食
3严重的疼痛；干扰经口摄入营养
4危及生命的后果；需紧急干预治疗
5死亡
1 Xu LH, Zhang HL, Liu JS, et al. Investigation of the oral infections and manifestations seen in patients with advanced cancer[J]. Pak J Med Sci, 2013, 29(5): 1112-1115.
2 Riley P, Glenny AM, Worthington HV, et al. Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and grow-th factors[J]. Cochrane Database Syst Rev, 2017, 11: CD011990.
3 Kusiak A, Jereczek-Fossa BA, Cichońska D, et al. Oncological-therapy related oral mucositis as an interdisciplinary problem-literature review[J]. Int J Environ Res Public Health, 2020, 17(7): E2464.
4 Reyes-Gibby CC, Wang J, Zhang LL, et al. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck[J]. Cancer, 2020, 126(23): 5124-5136.
5 Vozza I, Caldarazzo V, Ottolenghi L. Changes in microflora in dental plaque from cancer patients undergoing chemotherapy and the relationship of these changes with mucositis: a pilot study[J]. Med Oral Patol Oral Cir Bucal, 2015, 20(3): e259-e266.
6 Caselli E, Fabbri C, D’Accolti M, et al. Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture[J]. BMC Microbiol, 2020, 20(1): 120.
7 Kitamoto S, Nagao-Kitamoto H, Hein R, et al. The bacterial connection between the oral cavity and the gut diseases[J]. J Dent Res, 2020, 99(9): 1021-1029.
8 Tomkovich S, Jobin C. Microbiota and host immune responses: a love-hate relationship[J]. Immunology, 2016, 147(1): 1-10.
9 Xu Y, Teng F, Huang S, et al. Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy[J]. Arch Oral Biol, 2014, 59(2): 176-186.
10 Zhu XX, Yang XJ, Chao YL, et al. The potential effect of oral microbiota in the prediction of mucositis during radiotherapy for nasopharyngeal carcinoma[J]. EBioMedicine, 2017, 18: 23-31.
11 Oliva M, Schneeberger PHH, Rey V, et al. Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)[J]. Br J Cancer, 2021, 124(9): 1543-1551.
12 Hong BY, Sobue T, Choquette L, et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis[J]. Microbiome, 2019, 7(1): 66.
13 Sonalika WG, Amsavardani Tayaar S, Bhat KG, et al. Oral microbial carriage in oral squamous cell carcinoma patients at the time of diagnosis and during radiotherapy-a comparative study[J]. Oral Oncol, 2012, 48(9): 881-886.
14 Suryawanshi H, Ganvir SM, Hazarey VK, et al. Oropharyngeal candidosis relative frequency in radiotherapy patient for head and neck cancer[J]. J Oral Maxillofac Pathol, 2012, 16(1): 31-37.
15 Gaetti-Jardim E Jr, Jardim ECG, Schweitzer CM, et al. Supragingival and subgingival microbiota from patients with poor oral hygiene submitted to radiotherapy for head and neck cancer treatment[J]. Arch Oral Biol, 2018, 90: 45-52.
16 Chitapanarux I, Wongsrita S, Sripan P, et al. An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an ob-servation study[J]. BMC Oral Health, 2021, 21(1): 353.
17 Ramla S, Sharma V, Patel M. Influence of cancer treatment on the Candida albicans isolated from the oral cavities of cancer patients[J]. Support Care Cancer, 2016, 24(6): 2429-2436.
18 Jain M, Shah R, Chandolia B, et al. The oral carriage of candida in oral cancer patients of Indian origin undergoing radiotherapy and/or chemotherapy[J]. J Clin Diagn Res, 2016, 10(2): ZC17-ZC20.
19 Raj S, Sharma D, Mate P, et al. A study of changes in the oral fungal flora of patients on radiotherapy for head and neck malignancies and their correlation with funguria and fungemia[J]. Indian J Cancer, 2017, 54(1): 39-42.
20 Kurnatowski P, Moqbil S, Signs Kaczmarczyk D., symptoms and the prevalence of fungi detected from the oral cavity and pharynx of radiotherapy subjects with head and neck tumors, and their susceptibility to chemotherapeutics [J]. Ann Parasitol, 2014, 60(3): 207-213.
21 Villa A, Vollemans M, Moraes A, et al. Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers[J]. Support Care Cancer, 2021, 29(10): 6061-6068.
22 Kawashita Y, Soutome S, Umeda M, et al. Oral management strategies for radiotherapy of head and neck cancer[J]. Jpn Dent Sci Rev, 2020, 56(1): 62-67.
23 罗东华, 洪明晃, 郭灵, 等. 鼻咽癌放射性口腔粘膜炎多因素分析及建立判别模型的临床价值[J]. 癌症, 2005, 24(7): 850-854.
Luo DH, Hong MH, Guo L, et al. Analysis of oral mucositis risk factors during radiotherapy for nasopharyngeal carcinoma patients and establishment of a discriminant model[J]. Chin J Cancer, 2005, 24(7): 850-854.
24 Vidal-Casariego A, Fernández-Natal I, Calleja-Fernández A, et al. Nutritional, microbiological, and therapeutic factors related to mucositis in head and neck cancer patients: a cohort study[J]. Nutr Hosp, 2015, 32(3): 1208-1213.
25 Almståhl A, Finizia C, Carlén A, et al. Mucosal microflora in head and neck cancer patients[J]. Int J Dent Hyg, 2018, 16(4): 459-466.
26 Kumpitsch C, Moissl-Eichinger C, Pock J, et al. Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma[J]. Sci Rep, 2020, 10(1): 16582.
27 Singh GK, Capoor MR, Nair D, et al. Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy[J]. J Egypt Natl Canc Inst, 2017, 29(1): 33-37.
28 Nishii M, Soutome S, Kawakita A, et al. Factors associated with severe oral mucositis and candidiasis in patients undergoing radiotherapy for oral and oropharyngeal carcinomas: a retrospective multicenter study of 326 patients[J]. Support Care Cancer, 2020, 28(3): 1069-1075.
29 Zagury-Orly I, Khaouam N, Noujaim J, et al. The effect of radiation and chemoradiation therapy on the head and neck mucosal microbiome: a review[J]. Front Oncol, 2021, 11: 784457.
30 Shiao SL, Kershaw KM, Limon JJ, et al. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy[J]. Cancer Cell, 2021, 39(9): 1202-1213.e6.
31 Chen XF, Mims J, Huang XM, et al. Modulators of redox metabolism in head and neck cancer[J]. Antioxid Redox Signal, 2018, 29(16): 1660-1690.
32 Zong L, Li C, Zhong Y, et al. FTIR microspectroscopic investigation of Lactobacillus paracasei apoptosis induced by cisplatin[J]. Spectrochim Acta A Mol Biomol Spectrosc, 2021, 252: 119542.
33 Dedduwa-Mudalige GN, Chow CS. Cisplatin targeting of bacterial ribosomal RNA hairpins[J]. Int J Mol Sci, 2015, 16(9): 21392-21409.
34 Chen C, Zhang Q, Yu W, et al. Oral mucositis: an update on innate immunity and new interventional targets[J]. J Dent Res, 2020, 99(10): 1122-1130.
35 Stringer AM, Logan RM. The role of oral flora in the development of chemotherapy-induced oral mucositis[J]. J Oral Pathol Med, 2015, 44(2): 81-87.
36 Laheij AM, de Soet JJ, von dem Borne PA, et al. Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients[J]. Support Care Cancer, 2012, 20(12): 3231-3240.
37 Laheij AM, de Soet JJ. Can the oral microflora affect oral ulcerative mucositis[J]. Curr Opin Support Palliat Care, 2014, 8(2): 180-187.
38 Cogo K, Calvi BM, Mariano FS, et al. The effects of nicotine and cotinine on Porphyromonas gingivalis colonisation of epithelial cells[J]. Arch Oral Biol, 2009, 54(11): 1061-1067.
39 Bertolini M, Ranjan A, Thompson A, et al. Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection[J]. PLoS Pathog, 2019, 15(4): e1007717.
40 Sobue T, Bertolini M, Thompson A, et al. Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model[J]. Mol Oral Microbiol, 2018, 33(3): 212-223.
41 Diaz PI, Xie ZH, Sobue T, et al. Synergistic interaction between Candida albicans and commensal oral Streptococci in a novel in vitro mucosal model[J]. Infect Immun, 2012, 80(2): 620-632.
42 Xu H, Sobue T, Thompson A, et al. Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response[J]. Cell Microbiol, 2014, 16(2): 214-231.
43 Sharma A, Rath GK, Chaudhary SP, et al. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study[J]. Eur J Cancer, 2012, 48(6): 875-881.
44 de Sanctis V, Belgioia L, Cante D, et al. Lactobacillus brevis CD2 for prevention of oral mucositis in patients with head and neck tumors: a multicentric randomized study[J]. Anticancer Res, 2019, 39(4): 1935-1942.
45 Limaye SA, Haddad RI, Cilli F, et al. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy[J]. Cancer, 2013, 119(24): 4268-4276.
46 Xia CF, Jiang CL, Li W, et al. A phase Ⅱ randomized clinical trial and mechanistic studies using improved probiotics to prevent oral mucositis induced by concurrent radiotherapy and chemotherapy in nasopharyngeal carcinoma[J]. Front Immunol, 2021, 12: 618150.
47 Jiang CL, Wang H, Xia CF, et al. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma[J]. Cancer, 2019, 125(7): 1081-1090.
48 Xiao HW, Fan Y, Li Y, et al. Oral microbiota transplantation fights against head and neck radiotherapy-induced oral mucositis in mice[J]. Comput Struct Biotechnol J, 2021, 19: 5898-5910.
49 Wang Y, Li JT, Zhang HN, et al. Probiotic Streptococcus salivarius K12 alleviates radiation-induced oral mucositis in mice[J]. Front Immunol, 2021, 12: 684824.
50 Funahara R, Soutome S, Funahara M, et al. Effects of a miconazole oral patch on preventing development of oral candidiasis in patients with head and neck cancer undergoing radiotherapy: results of a pr-eliminary study quantifying the prevalence of Candida albicans in saliva[J]. Support Care Cancer, 2022, 30(1): 907-914.
[1] He Zimu, Li Fenglan. Present application of digital oral positioning stents in radiotherapy of head and neck tumor [J]. Int J Stomatol, 2024, 51(1): 28-35.
[2] Sun Xiaoqian, Zhang Jun. Advances in the effects of mechanical environment on the biological behaviors and mechanism of head and neck cancer [J]. Int J Stomatol, 2023, 50(4): 414-418.
[3] Chen Xiaoli,Zhang Fan,Liu Chengcheng. Application progress on photobiomodulation in the prevention and treatment of oral complications after radiothe-rapy [J]. Int J Stomatol, 2022, 49(6): 707-716.
[4] Li Hongfang,Chen Zhong,Zhang Suxin.. Research progress on immune checkpoint inhibitor combined with radiotherapy in head and neck squamous cell carcinoma [J]. Int J Stomatol, 2022, 49(5): 614-620.
[5] Wei Binbin,Hu Huiwei,Liu Yujuan,Sun Zhe,Yi Yuli. Meta-analysis and GRADE evaluation of the intervention effects of using amifostine before radiotherapy on xerostomia in patients with head and neck cancer [J]. Int J Stomatol, 2020, 47(5): 547-556.
[6] Chen Dong,Yang Zheng,Jiang Li. Research progress on the evaluation and management of radiation-induced xerostomia [J]. Int J Stomatol, 2019, 46(6): 711-717.
[7] Wei Binbin,Xiao Miao,Sun Zhe,Yi Yuli. Prevention and treatment strategy for oral mucositis by chemoradiotherapy in patients with nasopharyngeal carcinoma [J]. Int J Stomatol, 2019, 46(5): 558-564.
[8] Li Xiao, Ji Tong.. Chemotherapy in the treatment of osteosarcoma in oral maxillofacial-head and neck region [J]. Inter J Stomatol, 2017, 44(1): 83-86.
[9] Liu Pan1, Duolikun?Wufuer1, Cai Zhigang2, Sun Jian3. Clinical significance of serum squamous cell carcinoma antigens in Uyghur patients with oral squamous cell carcinoma [J]. Inter J Stomatol, 2016, 43(6): 645-650.
[10] Lü Danni, Li Ronglin, Yang Guangwei, Li Chunyang. Prevention and treatment of radiation- and chemotherapy-induced oral mucositis [J]. Inter J Stomatol, 2015, 42(2): 177-180.
[11] Chen Qi, Wu Yun. Therapeutic evaluation of Zhongtongan in the treatment of temporomandibular joint pain after radiotherapy [J]. Inter J Stomatol, 2015, 42(1): 24-27.
[12] Gu Qianping, Meng Jian, Meng Qingfei, Zhang Jie, Li Zhiping.. Clinical study on Nimotuzumab combined with Docetaxel-Cisplatin-Fluorouracil regimen in the treatment of advanced oral carcinoma [J]. Inter J Stomatol, 2011, 38(6): 652-655.
[13] WANG Ya-min, SONG Guang-bao.. The effects of radiotherapy on oral implantation [J]. Inter J Stomatol, 2011, 38(2): 204-206.
[14] ZHANG Jinge, TANG Wei, ZHANG Ping.. Clinical application on administration routes in the chemotherapy of head and neck cancer [J]. Inter J Stomatol, 2011, 38(2): 210-213.
[15] CHENG Shi-bing, XIE Hui-xu, LI Long-jiang.. Research progress of clinical application of thermochemotherapy of tumor [J]. Inter J Stomatol, 2010, 37(3): 337-337～340.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[9] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[10] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .